Impaired Mammary-Gland Development in Bmi1-Knockout Mice To evaluate the role of Bmi1 in mammary epithelium, we compared mammary glands from Bmi1 2/2 mice with those of their wild-type littermates by whole-mount analysis. At 5 weeks postpartum, mammary ducts in wild-type mice have started to colonize the fat pad under the influence of pubertal hormones. By this age the mammary glands exhibit Terminal End Buds (TEBs), containing stem cells and their highly proliferative progeny [9] , that have extended beyond the lymph nodes ( Figure 1A , left panel). In contrast, the development of the mammary gland in Bmi1 2/2 littermates was severely inhibited ( Figure 1A , right panel). Only occasionally did we observe an isolated TEB in a Bmi1 2/2 mammary gland. In general, the Bmi1-deficient ductal epithelium failed to invade the fat pad and mostly resembled the rudimentary mammary tree that is laid down during embryogenesis, indicating that Bmi1 plays an essential role in postnatal mammary development. Histological analysis of the Bmi1 2/2 mammary glands demonstrated that the mammary architecture remains intact, i.e., the mammary ducts consist of a single layer of luminal cells surrounded by a layer of myoepithelial cells ( Figure 1B ). This suggests that Bmi1 is not required to establish the fate of these cells. Immunostaining of wild-type mammary glands showed that Bmi1 expression is not restricted to a minority of the epithelial cells, as might be expected from a protein best known for its role in stem cells, but instead Bmi1 expression can be detected in all cells. Overall, Bmi1 expression is variable in TEBs, low in the myoepithelium, and highest in the luminal compartment ( Figure 1B and Figure S1 available online).
To determine whether the growth defect of Bmi1 2/2 mammary glands is due to a defect in the epithelial cells or caused by a deficiency in the environment of the cells, we isolated Bmi1 2/2 mammary epithelial cells (MECs), briefly expanded them in culture, and transplanted them into wild-type mice. When 100,000 MECs lacking Bmi1 were injected into cleared fat pads of wild-type mice, they still displayed a severe growth defect 10 weeks after transplantation, in contrast to wild-type cells that were injected contralaterally. To exclude possible artifacts from the in vitro culture, we repeated this experiment by transplanting a small piece of mammary tissue from the Bmi1 2/2 mice from the nipple area directly into the cleared fat pad of a wild-type mouse. Even though mammary epithelium was detectable upon transplantation, there was virtually no growth of the Bmi1-deficient tissue in contrast to wild-type tissue, demonstrating that Bmi1 expression in mammary epithelial cells is required for their proliferation ( Figure 1C) .
Several, but not all, defects of Bmi1 2/2 mice are caused by inappropriate Ink4a/Arf expression [10, 11] . p16 Ink4a and p19
Arf , which induce cell-cycle arrest and apoptosis through activation of Rb and p53, respectively, are not expressed in normal tissue but induced upon oncogenic signaling [12, 13] . In mammary epithelium, repression of the Ink4a/Arf locus is also dependent on Bmi1 because we found that the transcripts of both Ink4a and Arf are increased in Bmi1
MECs compared to wild-type MECs ( Figure S2 , bars on the left, labeled ''virgin''). When we codeleted the Ink4a/Arf locus together with Bmi1 and transplanted this Bmi1;Ink4a/ Arf-deficient mammary tissue and cells, we found an almost complete rescue of mammary growth ( Figure 1D ). This demonstrates that the lack of repression of the Ink4a/Arf locus is mostly responsible for the growth defect of Bmi1 2/2 tissue.
Because growth defects in mammary-gland development can often be rescued by pregnancy [14, 15] , we tested this for Bmi1 2/2 breast tissue as well. Because of the ill health of the Bmi1-knockout mice, we used transplanted Bmi1 2/2 tissue pieces in wild-type mice, which we mated with males 4 weeks after transplantation. Interestingly, we observed a near-complete rescue of Bmi1-deficient mammary outgrowth during pregnancy (Figure 2A ). We hypothesized that the strong growth stimulation during pregnancy could activate multiple pathways that result in inhibition of the cell-growth inhibitors p16
Ink4a and p19
Arf
. To test this, we isolated mammary epithelial cells from pregnant recipients that had been previously transplanted with wild-type and Bmi1
2/2
tissue and determined the expression of Ink4a and Arf. Surprisingly, Ink4a and Arf RNA and protein levels were still high in Bmi1-deficient tissue ( Figure S2 and Figure 2B ), even though there is extensive proliferation in these transplants ( Figure S2C ). Apparently, pregnancy hormones overcome the effects of these cell-cycle inhibitors to allow cell-cycle progression, possibly through induction of cyclin D1 [16] [17] [18] .
During pregnancy, lobules of alveolar cells are formed and differentiate to become sites of milk production, a process termed lobuloalveolar differentiation [9] . In pregnant recipients, this process occurs in the Bmi1-deficient outgrowths that are indistinguishable from the contralateral wild-type control transplants, as judged by morphology and histology. In addition, one of the constituents of milk, b-casein, is induced to comparable levels in transplants of Bmi1-deficient breast tissue and wild-type transplants ( Figure 3C ), indicating that the Bmi1-deficient mammary tissue is undergoing functional differentiation as well. This suggests that pregnancy can override the block in proliferation due to the absence of Bmi1, and Bmi1 is not required for lobuloalveolar differentiation.
Loss of Bmi1 Affects Both Mammary Stem Cells and Progenitors
The complete reconstitution of a mammary tree in pregnant recipients illustrates that mammary stem cells are present in the rudimentary mammary structures observed in the Bmi1 2/2 mouse. To obtain a quantitative measurement of the effect of Bmi1 loss in mammary stem cells in vivo, we performed limiting dilution transplantations. First, we transplanted Bmi1 2/2 tissue and wild-type tissue as a control into wild-type recipients. After rescuing the Bmi1 2/2 growth by pregnancy, we harvested these cells for use in a limiting dilution series in new recipients to analyze the minimum number of cells required for growth of mammary epithelial tissue; this number serves as an indication of the amount of stem cells that were present in the original cell isolate ( [6] , see Figure S3 for experimental set-up). When half a million cells are injected and the recipient is made pregnant, both wild-type and Bmi1-deficient cells are capable of reconstituting a mammary gland ( Figure S4A ). Upon reduction of the amount of injected cells, however, it becomes apparent that there is a 14-fold reduction in mammary repopulating units (MRUs) derived from the Bmi1 2/2 mammary gland (Table 1) . Apparently, mammary stem cells are less dependent on Bmi1 than for instance hematopoietic stem cells [2, 3, 19] .
To determine whether loss of the Ink4a/Arf locus can rescue stem cell activity in Bmi1-deficient mammary cells, we compared MECs with or without Bmi1 in the absence of the Ink4a/Arf locus. Also in this case, we first transplanted Bmi1/ Ink4a/Arf-deficient tissue and Ink4a/Arf-deficient tissue as a control into wild-type recipients to obtain sufficient cells for the limiting dilution ( Figure 1D and Figure S3 ). Loss of Ink4a/Arf by itself does not affect the repopulation activity ( Table 1 ), suggesting that Ink4a/Arf levels in wild-type stem cells are negligible. However, in Bmi1's absence, which results in derepression of the Ink4a/Arf locus, deletion of Ink4a/Arf does have an effect on stem cell activity, albeit partial (3-fold reduced compared to wild-type or Ink4a/Arf 2/2 cell isolates, Table 1 ). Importantly, the frequency of MRU remains similar in pregnant and virgin recipients (compare wild-types with Ink4a/Arf 2/2 , Table 1 ), consistent with previous reports demonstrating an increase in stem cells accompanying the increase in overall cell number during pregnancy [20] . Because we measure functional stem cell activity, we can not gauge the relative contribution of pregnancy-induced stem cells [21] , but our data demonstrate that there is an overall reduction in stem cell frequency in the absence of Bmi1. Because the rescue upon codeletion of the Ink4a/Arf locus was incomplete, it is likely that Bmi1 is required to repress additional target genes for the maintenance of mammary stem cells. Future studies should elucidate whether these target genes are additional cell-cycle regulators such as p21 [22] or whether they belong to the class of developmental regulators that are bound by PcG in ES cells [23] .
The fact that injections of high numbers of Bmi1-deficient MECs, containing multiple mammary stem cells, did not show any growth upon transplantation ( Figure 1C) suggests that proliferation of mammary progenitor cells is also hampered by the absence of Bmi1. In contrast, loss of hematopoietic stem cells in the Bmi1-deficient mouse is initially compensated by increased proliferation of their immediate descendants [3] . Furthermore, Molofsky et al. showed that neural progenitors from the forebrain proliferate normally in the absence of Bmi1 [4] , although granule cell precursor cells require Bmi1 for their proliferation [24] . These data indicate that not all progenitors are equally dependent on Bmi1 expression for their proliferation. There may be a tissue-specific dependency on silencing of PcG targets such as the Ink4a/Arf locus, which in certain circumstances might not be activated, or the function of Ink4a and Arf may be overruled downstream, thereby alleviating dependence on Bmi1 for proliferation. This is illustrated by our observation that pregnancy induces proliferation in the mammary gland, regardless of high Ink4a and Arf expression.
In vitro studies have suggested that in breast epithelium, like in neural cells, Bmi1 is a downstream effector of sonic hedgehog (Shh) signaling and is required for mammary stem cells [25] . In those studies, nonadherent cultures of human MECs, termed mammospheres, are used as a measurement for stem cell and progenitor activity. However, a recent publication showed that even though Shh activation in mouse MECs likewise increases the number of mammospheres, there is an actual reduction in the number of cells that are capable of reconstituting the mammary gland [26] . Therefore, the authors suggest that the mammosphere assay measures proliferation and anchorage-independent growth rather than stem cell activity. Our in vivo data demonstrate that loss of Bmi1 has an effect on mammary stem cell activity but is also required for proliferation of all progeny. Thus, the effect of Bmi1 loss in mammospheres probably reflects both functions of Bmi1: a partial loss of stem cell activity as well as a block in proliferation.
Bmi1 Prevents Premature Initiation of Lobuloalveolar Differentiation
Upon close examination, Bmi1 2/2 mammary tissue showed morphological signs of lobuloalveolar differentiation when it was transplanted into the fat pad of a virgin recipient. This suggests that without Bmi1, mammary cells may enter premature differentiation ( Figure 3A) . To further define this morphological phenotype in the Bmi1-deficient transplants, we used two well-established markers to discriminate between virgin and pregnant tissue, NKCC1 and Npt2b, respectively [27] . In the transplants of Bmi1 2/2 breast tissue, some ducts showed a virgin-like expression of NKCC1 (data not shown), but other structures have lost such NKCC1 staining, similar to pregnant tissue ( Figure 3B) .
The Na-Pi type IIb cotransporter (Npt2b) is not detectable in virgin tissue, but becomes expressed at the apical membrane from day 15 of pregnancy and remains present during lactation. Strikingly, in the Bmi1-deficient transplants more than The frequency of mammary-gland repopulating units (MRUs) was determined by limiting dilution transplantations of Bmi1 2/2 and wild-type MECs after rescue by pregnancy and for Bmi1/Ink4a/Arf and Ink4a/Arfdeficient cells in virgin recipients. See Figures S3 and S4 for experimental details. The fold reduction is relative to wild-type cells, and goodness of fit to a single-hit Poisson model was tested with standard Chi-square statistics.
half of the mammary structures expressed Npt2b, indicating that this process is normally repressed by Bmi1 in wild-type cells (Figures 3B and  3C) . Interestingly, when transplants from Bmi1/ Ink4a/Arf-deficient tissue were stained for Npt2b, the number of positive ducts was still increased compared to wild-type or Ink4a/Arf 2/2 transplants ( Figure 3C ). Since these cells are proliferating and reconstituting a cleared fat pad, this indicates that the precocious differentiation in the absence of Bmi1 alone is not initiated by expression of Ink4a and Arf or a default response to a block in proliferation. This suggests that Bmi1 generally prevents premature differentiation in the virgin mammary gland through repression of genes other than Ink4a and Arf.
To further substantiate the role of Bmi1 in lobuloalveolar differentiation, we manipulated Bmi1 levels in HC11 cells. This mouse mammary cell line can be induced to differentiate when the cells have established cell-cell contacts upon confluency combined with the addition of lactogenic hormones [28] . Functional differentiation can be subsequently quantified by determining the expression of milk proteins, such as b-casein [29] . Strikingly, knockdown of Bmi1 in HC11 cells greatly increased the b-casein production upon differentiation ( Figure 4A ). Conversely, overexpression of Bmi1 prevented b-casein expression completely, comparable to HC11 cells that have not been induced to differentiate ( Figure 4B ). This observation predicts that Bmi1 should be downregulated during pregnancy to allow efficient alveolar differentiation and milk production. We isolated MECs from two independent sets of mice at different stages of development and pregnancy. During the initial stages of pregnancy, Bmi1 levels are upregulated, possibly related to the increased mammary cell proliferation that occurs at this time. However, at later time points we observed a significant decrease in Bmi1 levels, especially during lactation and involution ( Figure 4C) .
In summary, a picture emerges whereby wild-type levels of Bmi1 are required to prevent spurious activation of terminal differentiation, whereas overexpression of Bmi1 inhibits activation of this program, even in the presence of the appropriate signals [30] . For instance, wild-type Bmi1 levels prevent Ink4a and Arf expression and thereby premature senescence. Upon oncogenic signaling such as constitutive activation of c-Myc or Ras, the Ink4a/Arf locus is expressed, which functions as a failsafe mechanism against tumorigenesis [31] . Bmi1 overexpression, however, overrules this tumor-suppressive response by hyperrepressing the Ink4a/Arf locus [32] . Overall, Bmi1 levels seem to determine the threshold for signals to activate its target genes. In the mammary gland, Bmi1 fulfills this function not only on the Ink4a/Arf locus, but also on (as-yet-unidentified) inducers of alveolar differentiation. Whereas genome-wide mapping of PcG targets in embryonic stem cells have already suggested a role for PcG proteins in preventing differentiation [23, 33] , we now show for the first time that Bmi1 is functionally required for the prevention of premature differentiation in more committed cells as well.
Implications for Breast Cancer
Several correlative studies implicate Bmi1 in breast cancer [7, 8] , but it is unknown whether Bmi1 has a causal role in this malignancy and if so, what is the relative importance of Bmi1's roles in the mammary gland. As our data show, Bmi1 affects mammary stem cells' proliferation and differentiation. Liu et al. observed that Bmi1 levels are increased in a subpopulation of breast cancer cells, and this led to the speculation that Bmi1 is involved in the self-renewal of cancer stem cells [25] . In addition, continuous overexpression of Bmi1 would be expected to prevent the tumor-suppressive activity of both Ink4a and Arf. A study by Yi et al. [34] suggested that loss of Arf endows mammary cells with indefinite reconstitution capacity. Overexpression of Bmi1 could have an analogous effect, namely prevention of Arf activation, thereby creating immortal cells. Moreover, Bmi1 overexpression may contribute to the immortality of mammary cells via induction of telomerase [7] . In that respect, it would be interesting to assess the serial transplantation capacity of Bmi1-overexpressing MECs. Our current study provides yet another possible contribution of Bmi1 overexpression to breast cancer: Bmi1 overexpression might contribute to an increase in the population of cells that could be susceptible to oncogenic transformation by blocking terminal differentiation. Together, our data demonstrate that Bmi1 is required for mammary-gland development during puberty but not for alveolar differentiation during pregnancy. We show that mammary stem cells are partially dependent on Bmi1 and that Bmi1 is required to allow proliferation of mammary epithelial cells and to prevent premature differentiation. The relative contributions of these functions of Bmi1 to its role in breast cancer will be the focus of our future studies. In general, our data illustrate the flexibility of epigenetic silencing by PcG proteins that cater to the plasticity that is required for cell-fate regulation during development and adult life.
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